AGIO
Agios Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +18.2% ·
share flow +7.2% ·
net new positions +15.4%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1.91M | $63.34M | n/a | n/a |
| Q2 2026 | 89 | +3 | 38.62M | $1.43B | +11 | −8 |
| Q1 2026 | 89 | 0 | 33.63M | $1.14B | +5 | −5 |
| Q4 2025 | 89 | -2 | 38.17M | $1.04B | n/a | −2 |
| Q3 2025 | 19 | +2 | 22.49M | $902.53M | +2 | −1 |
| Q2 2025 | 15 | 0 | 21.02M | $699.20M | n/a | n/a |
| Q1 2025 | 12 | -1 | 9.99M | $292.81M | n/a | −1 |
| Q4 2024 | 13 | +2 | 10.10M | $332.03M | +2 | n/a |
| Q3 2024 | 10 | 0 | 7.27M | $323.20M | n/a | n/a |
| Q2 2024 | 10 | n/a | 7.12M | $306.93M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.42M | -14.4% | $79.64M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 2.15M | n/a | $70.72M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.43M | +12116.0% | $47.11M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (passive) | 1.35M | -0.6% | $44.36M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 5 | Fisher Asset Management ✦ | 960.66K | +12.3% | $31.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 631.63K | -50.0% | $20.76M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 7 | D. E. Shaw & Co. ✦ | 516.48K | -3.0% | $16.97M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 303.00K | New | $9.96M | 0.0% | New | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 145.09K | -17.5% | $4.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 109.37K | New | $3.59M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 30.86K | -77.7% | $1.01M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 12 | Wellington Management ✦ | 25.49K | -13.4% | $837,568 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 13 | Millennium Management ✦ | 22.20K | -71.5% | $729,361 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $9.96M | 0.0% |
| Two Sigma Investments | $3.59M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 62.89M shares, $1.99B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.